OncoCyte and The Wistar Institute Announce Presentation of Lung Data at CHEST 2016 Annual Meeting
27 juil. 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, and The Wistar...
OncoCyte to Report Second Quarter Financial Results on August 11, 2016
21 juil. 2016 16h01 HE
|
Oncocyte Corporation
ALAMEDA, Calif., July 21, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that...
OncoCyte Presents Positive Bladder Cancer Diagnostic Data at the 2016 American Society of Clinical Oncology Annual Meeting
06 juin 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, is presenting data today from...
OncoCyte to Release Bladder Cancer Data at the 2016 American Society of Clinical Oncology Annual Meeting
19 mai 2016 09h45 HE
|
Oncocyte Corporation
ALAMEDA, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, released today the abstract of...
OncoCyte Reports First Quarter 2016 Financial Results
18 mai 2016 16h05 HE
|
Oncocyte Corporation
ALAMEDA, Calif., May 18, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, today reported its...
OncoCyte to Report First Quarter Financial Results on May 18, 2016
12 mai 2016 07h00 HE
|
Oncocyte Corporation
ALAMEDA, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that it...
OncoCyte’s Bladder Cancer Abstract to be Featured in a Poster Discussion Session at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting
21 avr. 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today...
OncoCyte and The Wistar Institute Announce Positive Results in the Development of a Blood-based Lung Cancer Test
04 avr. 2016 06h30 HE
|
Oncocyte Corporation
ALAMEDA, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, and The Wistar...
OncoCyte Corporation Reports Full Year 2015 Financial Results
30 mars 2016 08h00 HE
|
Oncocyte Corporation
ALAMEDA, Calif., March 30, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, reported its...
OncoCyte Corporation to Present at the 2016 BIO CEO & Investor Conference
02 févr. 2016 07h00 HE
|
Oncocyte Corporation
ALAMEDA, Calif., Feb. 02, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today that...